Bone Marrow Suppression Secondary to the COVID-19 Booster Vaccine: A Case Report

Posted on | Posted on John Murphy | Leave a Comment on Bone Marrow Suppression Secondary to the COVID-19 Booster Vaccine: A Case Report

TAuthors: oral Shastri 1, Navkiran Randhawa 2, Ragia Aly 3, Masood Ghouse 3 PMID: 35210894PMCID: PMC8863340DOI: 10.2147/JBM.S350290 J Blood Med.  2022; 13: 69–74.Published online 2022 Feb 18. doi: 10.2147/JBM.S350290 Abstract As of September 2021, SARS-CoV-2 booster shots became widely available in the US to ensure continued protection against the virus. A temporal relationship has been previously reported between the first or second dose of the COVID-19 vaccine […]

New Mutant “XE” Omicron Variant May Be The Most Transmissible Version Of Covid Yet, According To WHO

Posted on | Posted on John Murphy | Leave a Comment on New Mutant “XE” Omicron Variant May Be The Most Transmissible Version Of Covid Yet, According To WHO

Authors:  Tom Tapp March 31, 2022 4:46pm Deadline Breaking News Alerts The CDC announced this week that the BA.2 Omicron variant, which is reportedly 30% more transmissible than the original BA.1 Omicron strain — has become dominant among new cases sequenced in the United States. That’s a startling rise for a variant that was less than 1% of all sequences as recently […]

What You Should Know About Treating Covid-19

Posted on | Posted on John Murphy | Leave a Comment on What You Should Know About Treating Covid-19

Some therapies have been shown to work in clinical studies and other research Authors: Jared S. Hopkins Updated Mar. 31, 2022 3:12 pm ET Talhe Wall Street Journal The Food and Drug Administration authorized the first antiviral pills to treat Covid-19 from Pfizer Inc. and Merck & Co. and partner Ridgeback Biotherapeutics LP in December. The authorizations came after each drugmaker’s […]

This New COVID Variant Is the Most Unpredictable One Yet

Posted on | Posted on John Murphy | Leave a Comment on This New COVID Variant Is the Most Unpredictable One Yet

Authors: David Axe Published Apr. 03, 2022 10:47PM ET  After spreading across Asia and Europe, the BA.2 subvariant of the novel coronavirus is now dominant in the United States, according to the U.S. Centers for Disease Control and Prevention. Right now, U.S. COVID cases are at a six-month low. But what happens next in the U.S. and nearby countries is hard to predict. Looking to Europe […]

Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates

Posted on | Posted on John Murphy | Leave a Comment on Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates

Authors: Ibolya Rutkai, Meredith G. Mayer, Linh M. Hellmers, Bo Ning, Zhen Huang, Christopher J. Monjure, Carol Coyne, Rachel Silvestri, Nadia Golden, Krystle Hensley, Kristin Chandler, Gabrielle Lehmicke, Gregory J. Bix, Nicholas J. Maness, Kasi Russell-Lodrigue, Tony Y. Hu, Chad J. Roy, Robert V. Blair, Rudolf Bohm, Lara A. Doyle-Meyers, Jay Rappaport & Tracy Fischer  Nature Communications volume 13, Article number: 1745 (2022)  Published: 01 April 2022 Abstract Neurological manifestations are a significant complication of coronavirus disease (COVID-19), but underlying mechanisms aren’t well […]

COVID can cause lingering brain damage — even in mild cases

Posted on | Posted on John Murphy | Leave a Comment on COVID can cause lingering brain damage — even in mild cases

Authors: Chris Melore Study Finds APRIL 1, 2022 COVID-19 started as a serious threat to the lungs, but it’s become just as synonymous with brain issues throughout the pandemic. Now, a new study is revealing exactly how the virus damages the central nervous system. Researchers at Tulane University say even a mild COVID infection can […]

Two New Studies Offer a First Model for Diagnosing, Monitoring and Treating Long COVID

Posted on | Posted on John Murphy | Leave a Comment on Two New Studies Offer a First Model for Diagnosing, Monitoring and Treating Long COVID

Two new studies propose the first model for diagnosing, indexing and monitoring Post-Acute Sequelae of COVID-19 (PASC), also known as long COVID or long haul COVID. The findings also provide a framework for understanding the cause of, and potential treatment for, long COVID. Long COVID is believed to affect as many as 30 percent of […]

Long COVID from rheumatology perspective — a narrative review

Posted on | Posted on John Murphy | Leave a Comment on Long COVID from rheumatology perspective — a narrative review

Authors: Hem Raj Sapkota1 and Arvind Nune2 Clin Rheumatol. 2022; 41(2): 337–348.Published online 2021 Nov 30. doi: 10.1007/s10067-021-06001-1PMCID: PMC8629735PMID: 34845562 Abstract Long-term sequel of acute COVID-19, commonly referred to as long COVID, has affected millions of patients worldwide. Long COVID patients display persistent or relapsing and remitting symptoms that include fatigue, breathlessness, cough, myalgia, arthralgia, sleep disturbance, cognitive impairment and skin rashes. […]

Long-term complications of COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Long-term complications of COVID-19

Authors: Amar D. Desai,*Michael Lavelle,*Brian C. Boursiquot, and Elaine Y. Wan Am J Physiol Cell Physiol. 2022 Jan 1; 322(1): C1–C11.Published online 2021 Nov 24. doi:  10.1152/ajpcell.00375.2021PMCID: PMC8721906PMID: 34817268 Abstract SARS-CoV-2 has rapidly spread across the globe and infected hundreds of millions of people worldwide. As our experience with this virus continues to grow, our understanding of both short-term and […]

Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

Posted on | Posted on John Murphy | Leave a Comment on Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

Authors:  Pooja Toshniwal PahariaMar 24 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the medRxiv* preprint server, researchers assessed the prevalence of organ impairment in long coronavirus disease 2019 (COVID-19) six months and a year post-COVID-19 at London and Oxford. Multi-organ impairment associated with long COVID-19 is a significant health burden. Standardized multi-organ evaluation […]